Assertio Holdings Overview
- Year Founded
-
1995
- Status
-
Acquired/Merged
- Employees
-
60
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$101M
Assertio Holdings General Information
Description
Assertio Holdings Inc is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients' needs. The group's focus is on supporting patients by marketing oncology, neurology, and pain management products.
Contact Information
Website
www.assertiotx.com(Operating Subsidiary)
Corporate Office
- 100 South Saunders Road
- Suite 300
- Lake Forest, IL 60045
- United States
Corporate Office
- 100 South Saunders Road
- Suite 300
- Lake Forest, IL 60045
- United States
Assertio Holdings Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 17. Merger/Acquisition | 16-Jun-2026 | $101M | Completed | Generating Revenue | ||
| 16. PIPE | 12-Feb-2021 | Completed | Generating Revenue | |||
| 15. PIPE | 09-Feb-2021 | Completed | Generating Revenue | |||
| 14. Debt Refinancing | 13-Aug-2017 | Cancelled | Profitable | |||
| 13. Buyout/LBO | Cancelled | Profitable | ||||
| 12. Debt Repayment | 04-Apr-2016 | Completed | Profitable | |||
| 11. Merger/Acquisition | 19-Nov-2015 | Cancelled | Profitable | |||
| 10. Debt - Acquisition | 12-Mar-2015 | Completed | Profitable | |||
| 9. Secondary Transaction - Private | 01-Jan-2006 | $61.3M | Completed | Generating Revenue | ||
| 8. PIPE | 22-Apr-2003 | $20M | $61.3M | Completed | Generating Revenue |
Assertio Holdings Comparisons
Industry
Financing
Details
Assertio Holdings Competitors (26)
One of Assertio Holdings’s 26 competitors is Genzyme Ireland, a Corporation company based in Kilmeaden, Ireland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genzyme Ireland | Corporation | Kilmeaden, Ireland | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| Pfizer Pakistan | Corporation | Karachi, Pakistan | ||||
| Grifols | Corporation | Barcelona, Spain | ||||
| Johnson&Johnson Innovative Medicine | Venture Capital-Backed | Raritan, NJ |
Assertio Holdings Patents
Assertio Holdings Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2016100564-A1 | Liquid dispensing device with electronic counting component | Inactive | 16-Dec-2014 | ||
| US-20140066411-A1 | Pharmaceutical compositions for extended release of azo-bonded 5-aminosalicylic acid compositions | Inactive | 28-Aug-2012 | ||
| US-20130316002-A1 | Compositions and methods for treating gastrointestinal motility dysfunction | Inactive | 22-May-2012 | ||
| CA-2850468-A1 | Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract | Active | 28-Sep-2010 | ||
| CA-2850468-C | Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract | Inactive | 28-Sep-2010 | A61K9/0065 |
Assertio Holdings Signals
Assertio Holdings Former Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Biovail | Corporation | Minority | ||
| CSO Ventures | Corporation | Minority | ||
| Cygnus Therapeutics Systems | Other | Minority | ||
| Deerfield Management | Venture Capital | Minority | ||
| Easton Capital Investment Group | Venture Capital | Minority |
Assertio Holdings Investments & Acquisitions (10)
Assertio Holdings’s most recent deal was a Merger/Acquisition with Spectrum Pharmaceuticals for . The deal was made on 31-Jul-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Spectrum Pharmaceuticals | 31-Jul-2023 | Merger/Acquisition | Drug Discovery | ||
| Sympazan | 27-Oct-2022 | Merger/Acquisition | Pharmaceuticals | ||
| Antares Pharma (Otrexup Injection Treatment Medicine) | 15-Dec-2021 | Corporate Asset Purchase | Buildings and Property | ||
| Zyla Life Sciences | 20-May-2020 | Merger/Acquisition | Drug Delivery | ||
| Slán Medicinal Holdings (Cosyntropin Depot) | 07-Nov-2017 | Corporate Asset Purchase | Buildings and Property |
Assertio Holdings ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
39.12 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Assertio Holdings Affiliates
Subsidiaries (5)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Antares Pharma (Otrexup Injection Treatment Medicine) | Ewing, NJ | 2014 | |
| Spectrum Pharmaceuticals | Boston, MA | 1987 | |
| Assertio Distribution | Lake Forest, IL | ||
| Assertio Management | Lake Forest, IL | ||
| Depo Dr Sub | Lake Forest, IL |
Assertio Holdings FAQs
-
When was Assertio Holdings founded?
Assertio Holdings was founded in 1995.
-
Where is Assertio Holdings headquartered?
Assertio Holdings is headquartered in Lake Forest, IL.
-
What is the size of Assertio Holdings?
Assertio Holdings has 60 total employees.
-
What industry is Assertio Holdings in?
Assertio Holdings’s primary industry is Pharmaceuticals.
-
Is Assertio Holdings a private or public company?
Assertio Holdings is a Private company.
-
What is the current valuation of Assertio Holdings?
The current valuation of Assertio Holdings is .
-
What is Assertio Holdings’s current revenue?
The current revenue for Assertio Holdings is .
-
How much funding has Assertio Holdings raised over time?
Assertio Holdings has raised $685M.
-
Who are Assertio Holdings’s investors?
Biovail, CSO Ventures, Cygnus Therapeutics Systems, Deerfield Management, and Easton Capital Investment Group are 5 of 13 investors who have invested in Assertio Holdings.
-
Who are Assertio Holdings’s competitors?
Genzyme Ireland, Pfizer (Vienna), Pfizer Pakistan, Grifols, and Johnson&Johnson Innovative Medicine are some of the 26 competitors of Assertio Holdings.
-
When was Assertio Holdings acquired?
Assertio Holdings was acquired on 16-Jun-2026.
-
Who acquired Assertio Holdings?
Assertio Holdings was acquired by Zydus Lifesciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process